FCGR2B and rheumatoid arthritis: Thus, the Fab portion recognized CD19 expressed by B cells, and its Fc portion engages with the unique FcγR expressed on B cells, FcγRIIB, which is responsible for their inhibition and the reduction in the production of pathogenic antibodies, as demonstrated in vitro with B cells from rheumatoid arthritis patients [99].